Thrombectomy is the surgical removal of blood clot from a blood vessel. Venous thromboembolism (VTE) is a common lethal disease where blood clots within a vein. These clots can travel to arteries or veins in different parts of the body-brain, heart, kidneys, lungs, and limbs. VTE is considered as the cause of heart attack, stroke; however, it can also damage to the body's organs or even death. VTE results due to various factors, which include combination of hereditary and acquired risk factors, obesity and post-surgery especially hip, knee, or pelvic surgery. It can be found in smoking population and people who take estrogens or birth control pills. VTE is most common in adults (>60 years) but can occur at any age.
The world thrombectomy devices market is estimated to garner $1,389 million by 2022. This is attributed by the increase in the incidence of acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, and pulmonary embolism due to the sedentary lifestyle, and unhealthy living conditions and habits in the current generation; rise in the geriatric population. The increase in incidence of cardiovascular diseases; growth in demand for minimally-invasive procedures, and demand for better healthcare infrastructure; and increase in competition, has led to technological advancements and innovations. However, lack of trained professionals and awareness, and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by avoiding sedentary lifestyle and creating awareness among all.
The world thrombectomy devices market is segmented into five categories-technology, type, utility, disease, and geography. Based on the type of technology, the market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, rheolytic thrombectomy devices. Based on type, the market is divided into automated devices and manual devices. Based on utility, the market is classified into reusable devices and disposable devices. The thrombectomy devices market is segmented into three disease categories, which include peripheral diseases, coronary diseases, and neuro diseases. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players in the thrombectomy devices market. On September 2015, Medtronic acquired Lazarus Effect to strengthen its market of clot removal devices effective during ischemic stroke. Boston Scientific completed the acquisition of interventional business of Bayer AG on May 2014. This made Boston Scientific the leading innovator for peripheral vascular disease in the industry, and expanded their product portfolio and sales force across various geographies.
KEY MARKET BENEFITS:
The quantitative analysis of the current trends and future estimations from 2014 to 2022 is provided to identify the prevailing opportunities and formulate growth strategies.
In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.
A detailed analysis based on technology is presented to understand the type of products in trend or would be in demand to assist in product developments and collaborations.
Comprehensive analysis of the market drivers and constraints is provided to identify the prevailing market opportunities.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.
KEY MARKET SEGMENTS:
The world thrombectomy devices market segmentation is illustrated as follows:
By Technology
Mechanical Thrombectomy Devices
Aspiration Thrombectomy Devices
Rheolytic Thrombectomy Devices
By Type
Automated Devices
Manual Devices
By Utility
Reusable Devices
Disposable Devices
By Diseases
Peripheral Diseases
Coronary Diseases
Neural Diseases
By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Spain
Italy
Others
Asia-Pacific
China
Japan
India
Others
LAMEA
Brazil
Saudi Arabia
South Africa
Others
Company profiles
Boston Scientific Corporation
Medtronic Plc
Teleflex Incorporated
Penumbra Inc.
The Spectranetics Corporation
AngioDynamics, Inc.
Terumo Corporation
Johnson and Johnson, Inc.
Stryker Corporation
Vascular Solutions, Inc.
